SecBot SecBot
8-K ·Filed Jul 31, 2026

OSRH

OSR Health, Inc.
NEUTRAL
Impact 4/10
Horizonweeks Processed2mo ago SEC0001213900-26-083878
8-K context-dependent: Items 7.01
Actionable Insight • Neutral

Monitor the August 14 record date and any subsequent SEC filings regarding securities-law clearance for the CVR program. The removal of price-adjustment risk is a modest positive for the program's viability, but the lack of financial data and ongoing regulatory uncertainty limit near-term trading conviction.

DirectionNeutral
Confidencemedium
Horizonweeks
Final — all horizons settled through T+60d
OSRH ▼ -74.00% at T+60d
NEUTRAL call -74.00% · α vs SPY -76.45% · entry $0.4480 → $0.1165
Entry = T+0 close
Jul 31, 2026
via day close
T+1d
-0.42%
call -0.42% · α -1.85%
$0.4461
settled 3mo ago
T+5d
-1.12%
call -1.12% · α -4.63%
$0.4430
settled 3mo ago
T+20d
-74.00%
call -74.00% · α -76.98%
$0.1165
settled 2mo ago
T+60d
-74.00%
call -74.00% · α -76.45%
$0.1165
settled yesterday

Price Chart

Loading chart...

Executive Summary

OSR Health disclosed that Nasdaq verbally confirmed its Shareholder Loyalty CVR program will not trigger a mechanical price adjustment to OSRH common stock upon CVR distribution or share delivery. The record date is August 14, 2026. This removes a key structural overhang for the program but does not address securities-law requirements, which remain subject to ongoing regulatory process.

Key Facts

  • Nasdaq confirmed no mechanical price adjustment to OSRH common stock from the CVR program distribution or share deliveries.
  • Record date for CVR eligibility is August 14, 2026.
  • Enrolled shareholders receive additional shares at no cost if closing-price milestones are met over four measurement dates in 12 months.
  • Securities-law requirements for the CVR distribution remain subject to ongoing regulatory process.

Financial Impact

No financial figures disclosed; program is contingent on meeting unspecified price milestones.

Risk Factors

  • CVR program remains subject to securities-law regulatory process, which could delay or alter terms.
  • Program's value depends on achieving undefined closing-price milestones; no guarantee of shareholder benefit.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001213900-26-083878
Document: ea030011101ex99-1.htm0001213900-26-083878
Document: 0001213900-26-083878-index-headers.html0001213900-26-083878
Document: 0001213900-26-083878-index.html0001213900-26-083878
Document: 0001213900-26-083878.txt0001213900-26-083878
7 reports for OSRH
Performance horizon
33% Hit rate @ T+20 1 of 3 directional calls Went positive at some point 1 of 4 best @ T+5▲ +60.50%Aug 19, 2026
Filters
Rows
Reports for OSRH — sortable, filterable
TypeNow
Oct 16, 2026
11d ago
8-K
BEARISH ★ 6/10
$0.1165awaiting T+20—$0.1930 (−65.67%)
Oct 2, 2026
24d ago
8-K
NEUTRAL ★ 3/10
$0.2410awaiting T+20—$0.1930 (−19.92%)
Aug 28, 2026
8w ago
8-K
BEARISH ★ 7/10
$0.1165 $0.1165· 0.00%▲ +0.26%$0.1930 (−65.67%)
Aug 25, 2026
9w ago
8-K
BEARISH ★ 8/10
$0.1165 $0.1165· 0.00%▲ +0.98%$0.1930 (−65.67%)
Aug 19, 2026
9w ago
8-K
BEARISH ★ 8/10
$0.2949 $0.1165▲ +60.50%▲ +60.50%$0.1930 (+34.55%)
Jul 31, 2026
12w ago
8-K
NEUTRAL ★ 4/10
$0.4480 $0.1165▼ −74.00%▼ −76.98%$0.1930 (−56.92%)
Jun 11, 2026
19w ago
DEFA14A
NEUTRAL ★ 2/10
$0.4192 $0.3290▼ −21.52%▼ −23.41%$0.1930 (−53.96%)
Showing 7 of 7

US Market Status

Market Open — Closes in 2h 39m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 31, 2026